ScholarIQanswers from OpenAlex & ORCID
Claudio Ponticelli
ResearcherPublications, citations & collaboration network
Claudio Ponticelli is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Claudio Ponticelli have?
ScholarIQindexed works
Claudio Ponticelli has 67 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Claudio Ponticelli have?
ScholarIQcitation count
Claudio Ponticelli has 1,990 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Claudio Ponticelli?
ScholarIQh-index
Claudio Ponticelli has an h-index of 18 in OpenAlex.
What is the i10-index of Claudio Ponticelli?
ScholarIQi10-index
Claudio Ponticelli has an i10-index of 28 in OpenAlex.
What is the ORCID of Claudio Ponticelli?
ScholarIQorcid
The ORCID for Claudio Ponticelli is on the source record.
What is the OpenAlex record for Claudio Ponticelli?
ScholarIQopenalex
The OpenAlex for Claudio Ponticelli is on the source record.
What are the most-cited papers on Claudio Ponticelli?
ScholarIQmost cited works
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Claudio Ponticelli, Paolo Altieri, Francesco Scolari, P Passerini, Dario Roccatello, B. Cesana, Patrizia Melis, Brunella Valzorio, Mauro Sasdelli, Stefano Pasquali, Claudio Pozzi, Giuseppe Piccoli, Antonio Lupo, S Segagni, F.P. Antonucci, Mauro Dugo, M Minari, A Scalia, Luciano A. Pedrini, Giuseppe Pisano, C Grassi, Marco Farina, Riccardo Bellazzi
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
Claudio Ponticelli, Gianfranco Rizzoni, Alberto Edefonti, Paolo Altieri, Emilio Rivolta, Stefano Rinaldi, Luciana Ghio, E Lusvarghi, R Gusmano, Francesco Locatelli, Sonia Pasquali, A Castellani, O. Della Casa-Alberighi
Kidney transplantation in patients with IgA mesangial glomerulonephritis11See Editorial by Hogg, p. 2033.
Claudio Ponticelli, Lara Traversi, Annalisa Feliciani, Bruno Mario Cesana, Giovanni Banfi, Antonio Tarantino
A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,2
Claudio Ponticelli, Alexander Yussim, V. Cambi, Christophe Legendre, Gaetano Rizzo, Maurizio Salvadori, Delawir Kahn, Habib Kashi, K. Salmela, Lutz Fricke, Uwe Heemann, Javier García-Martínez, Robert I. Lechler, H. Prestele, Danièle Girault
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Claudio Ponticelli, M Villa, Giovanni Banfi, Bruno Mario Cesana, Claudio Pozzi, Antonello Pani, P Passerini, Marco Farina, Claudio Grassi, Ambrogio Baroli